GB10, a best-in-class antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-16 17:20:58 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.21203/rs.3.rs-5135499/v1
文献链接: https://www.researchsquare.com/article/rs-5135499/v1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Xiling Wei; Yuxin Qiu; Wei Shang; Xiangling Zhang; Wenjie Yang; Chengyong Yang; Xi Chen; Huiming Li; Suofu Qin

